# Takeda Pharmaceutical Company Limited – FDA Inspection, Mar 9, 2011

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/b676ef63-86fc-41ac-b4ba-b631199b3f88
Source feed: FDA_Inspections

> FDA inspection 712228 of Takeda Pharmaceutical Company Limited, March 09, 2011. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 712228
- Company Name: Takeda Pharmaceutical Company Limited
- Inspection Date: 2011-03-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1099764 - 2019-07-30
- FDA Inspection 975877 - 2016-06-15
- FDA Inspection 934717 - 2015-07-09
- FDA Inspection 844248 - 2013-08-14
- [FDA Inspection 599120 - 2009-06-11](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceutical-company-limited/8dab6079-805e-47c4-bb6b-42e310fda99c)

Company: https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/25f21beb-881d-4ad2-8a27-91f7e246d4c6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d